Cargando…
Limited Neutralization of Omicron by Antibodies from the BNT162b2 Vaccination against SARS-CoV-2
Since early December 2021, the omicron variant has posed additional challenges to the world-wide management of the SARS-CoV-2 pandemic. Immune evasion is a key factor for its increased transmissibility. While serological studies have measured levels of neutralizing antibodies in response to vaccines...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
American Journal Experts
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9016652/ https://www.ncbi.nlm.nih.gov/pubmed/35441169 http://dx.doi.org/10.21203/rs.3.rs-1518378/v1 |